Glycemic Trajectories and Treatment Outcomes of Patients with Newly Diagnosed Tuberculosis: A Prospective Study in Eastern China
- PMID: 33705666
- DOI: 10.1164/rccm.202007-2634OC
Glycemic Trajectories and Treatment Outcomes of Patients with Newly Diagnosed Tuberculosis: A Prospective Study in Eastern China
Abstract
Rationale: Patients with newly diagnosed tuberculosis often have inconsistent glycemic measurements during and after treatment. Distinct glycemic trajectories after the diagnosis of tuberculosis are not well characterized, and whether patients with stress hyperglycemia have poor treatment outcomes is not known.Objectives: To identify distinct glycemic trajectories from the point of tuberculosis diagnosis to the posttreatment period and to assess the relationship between glycemic trajectories and tuberculosis treatment outcomes.Methods: Patients with newly diagnosed, drug-susceptible tuberculosis and with at least three fasting plasma glucose tests at tuberculosis diagnosis and during the third and sixth month of treatment were identified and included from Jiangsu Province, China. Patients were also given an additional fasting plasma glucose test at 2 and 4 months after treatment.Measurements and Main Results: Several distinct glycemic trajectories from the point of tuberculosis diagnosis to the posttreatment period were found, including consistently normal glycemic testing results (43%), transient hyperglycemia (24%), erratic glycemic instability (12%), diabetes (16%), and consistent hyperglycemia without diabetes (6%). Compared with participants with a consistently normal glycemic trajectory, patients with transient hyperglycemia were more likely to experience treatment failure (adjusted odds ratio [AOR], 4.20; 95% confidence interval [CI], 1.57-11.25; P = 0.004) or erratic glycemic instability (AOR, 5.98; 95% CI, 2.00-17.87; P = 0.001). Patients living with diabetes also had a higher risk of experiencing treatment failure (AOR, 6.56; 95% CI, 2.22-19.35; P = 0.001), and this was modified by glycemic control and metformin use.Conclusions: Among patients with tuberculosis without diabetes, glycemic changes were common and may represent an important marker for patient response to tuberculosis treatment.
Keywords: diabetes; hyperglycemia; treatment outcomes; tuberculosis.
Comment in
-
Is Glycemic Control the Secret to Tuberculosis Control?Am J Respir Crit Care Med. 2021 Aug 1;204(3):254-255. doi: 10.1164/rccm.202103-0703ED. Am J Respir Crit Care Med. 2021. PMID: 33826869 Free PMC article. No abstract available.
Similar articles
-
Transient Hyperglycemia in Patients With Tuberculosis in Tanzania: Implications for Diabetes Screening Algorithms.J Infect Dis. 2016 Apr 1;213(7):1163-72. doi: 10.1093/infdis/jiv568. Epub 2015 Nov 25. J Infect Dis. 2016. PMID: 26609005
-
Role of Diabetes Mellitus on Treatment Effects in Drug-susceptible Initial Pulmonary Tuberculosis Patients in China.Biomed Environ Sci. 2017 Sep;30(9):671-675. doi: 10.3967/bes2017.089. Biomed Environ Sci. 2017. PMID: 29081342
-
Outcomes associated with hyperglycemia after abdominal aortic aneurysm repair.J Vasc Surg. 2019 Mar;69(3):763-773.e3. doi: 10.1016/j.jvs.2018.05.240. Epub 2018 Aug 25. J Vasc Surg. 2019. PMID: 30154015 Free PMC article.
-
Metformin in tuberculosis: beyond control of hyperglycemia.Infection. 2019 Oct;47(5):697-702. doi: 10.1007/s15010-019-01322-5. Epub 2019 May 22. Infection. 2019. PMID: 31119504 Review.
-
Metformin: A review of its potential as enhancer for anti tuberculosis efficacy in diabetes mellitus-tuberculosis coinfection patients.Indian J Tuberc. 2019 Apr;66(2):294-298. doi: 10.1016/j.ijtb.2019.02.013. Epub 2019 Mar 8. Indian J Tuberc. 2019. PMID: 31151499 Review.
Cited by
-
Altered hepatic metabolic landscape and insulin sensitivity in response to pulmonary tuberculosis.PLoS Pathog. 2024 Sep 27;20(9):e1012565. doi: 10.1371/journal.ppat.1012565. eCollection 2024 Sep. PLoS Pathog. 2024. PMID: 39331683 Free PMC article.
-
Hyperglycemia and Lung Cancer-A Possible Relationship.Diagnostics (Basel). 2025 Mar 7;15(6):651. doi: 10.3390/diagnostics15060651. Diagnostics (Basel). 2025. PMID: 40149994 Free PMC article. Review.
-
Cardiometabolic Biomarkers and Systemic Inflammation in US Adolescents and Young Adults With Latent Tuberculosis Infection: A Population-Based Cohort Study.Open Forum Infect Dis. 2025 Mar 28;12(4):ofaf194. doi: 10.1093/ofid/ofaf194. eCollection 2025 Apr. Open Forum Infect Dis. 2025. PMID: 40242065 Free PMC article.
-
How can tuberculosis services better support patients with a diabetes co-morbidity? A mixed methods study in the Philippines.BMC Health Serv Res. 2023 Sep 25;23(1):1027. doi: 10.1186/s12913-023-10015-7. BMC Health Serv Res. 2023. PMID: 37749519 Free PMC article.
-
Diabetes Status and Association With Risk of Tuberculosis Among Korean Adults.JAMA Netw Open. 2021 Sep 1;4(9):e2126099. doi: 10.1001/jamanetworkopen.2021.26099. JAMA Netw Open. 2021. PMID: 34546370 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical